The Role of Endoscopy in Secondary Prophylaxis of Esophageal Varices

Clinics in Liver Disease

Volumn 14, Issue 2, 2010, Pages 307-323

  Lo, Gin Ho ^a,b  

^a E DA HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

Author keywords

Banding ligation; Endoscopic therapy; Endoscopy; Sclerotherapy; Variceal rebleeding

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ENBUCRILATE; ISOSORBIDE MONONITRATE; NADOLOL; PROPRANOLOL; SCLEROSING AGENT; SUCRALFATE;

CLINICAL TRIAL; CLIP; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES; HUMAN; INTERMETHOD COMPARISON; MICROWAVE THERAPY; MINIMALLY INVASIVE PROCEDURE; MORBIDITY; MORTALITY; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; REVIEW; SECONDARY PREVENTION; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ADRENERGIC BETA-ANTAGONISTS; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; LIGATION; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RECURRENCE; SCLEROTHERAPY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 77952976936     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2010.03.009     Document Type: Review

References (107)

1. Graham D.Y., and Smith J.L. The course of patients after variceal hemorrhage. Gastroenterology 80 (1981) 800-809
2. D'Amico G., and de Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 38 (2003) 599-612
3. Mihas A.A., and Sanyal A.J. Recurrent variceal bleeding despite endoscopic and medical therapy. Gastroenterology 127 (2004) 621-629
4. Hou M.C., Lin H.C., Liu T.T., et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized controlled trial. Hepatology 39 (2004) 746-753
5. Patch D., Armonis A., Sabin C., et al. Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding. Gut 44 (1999) 264-269
6. Lo G.H., Lai K.H., Ng W.W., et al. Injection sclerotherapy preceded by esophageal tamponade versus immediate sclerotherapy in arresting active variceal bleeding: a prospective randomized trial. Gastrointest Endosc 38 (1992) 421-424
7. de Franchis R., and Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 5 (2001) 645-663
8. Bosch J., and Garcia-Pagan J.C. Prevention of variceal rebleeding. Lancet 361 (2003) 952-954
9. Sharara A.I., and Rockey D.C. Gastroesophageal variceal hemorrhage. N Engl J Med 345 (2001) 669-681
10. Lo G.H. Prevention of esophageal variceal rebleeding. J Chin Med Assoc 69 (2006) 553-560
11. Burroughs A.K., Cales P., Kravetz D., et al. Definition of key events-last attempt?. Proceedings of the fourth Baveno International Consensus Workshop. In: de Franchis R. (Ed). Portal hypertension IV (2006), Blackwell Publishing, Oxford 11-39
12. Crafoord C., and Frenckner P. New surgical treatment of varicose veins of the esophagus. Acta Otolaryngol (Stockholm) 27 (1939) 422-429
13. Sanowski R.A., and Waring J.P. Endoscopic techniques and complications in variceal sclerotherapy. J Clin Gastroenterol 9 (1987) 504-513
14. Jensen D.M., Machicado G.A., and Silpa M. Esophageal varix hemorrhage and sclerotherapy-animal studies. Endoscopy 18 Suppl 2 (1986) 18-22
15. Westaby D., Melai W.M., MacDougall B.R.D., et al. Injection sclerotherapy for esophageal varices: a prospective, randomized trial of different treatment schedules. Gut 25 (1984) 129-132
16. Conn H.O. Endoscopic sclerotherapy: an analysis of variants. Hepatology 3 (1983) 769-771
17. Johnston G.W., and Rodgers H.W. A review of 15 years' experience in the use of sclerotherapy in the control of acute hemorrhage from esophageal varices. Br J Surg 60 (1973) 797-800
18. Macdougall B.R., Westaby D., Theodossi A., et al. Increased long-term survival in variceal hemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet 1 (1982) 124-127
19. Terblanche J., Bornman P.C., Kahn D., et al. Failure of repeated injection sclerotherapy to improve long-term survival after esophageal variceal bleeding. A five-year prospective controlled clinical trial. Lancet 2 8363 (1983) 1328-1332
20. Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. The Copenhagen Esophageal Varices Sclerotherapy Project. N Engl J Med 311 (1984) 1594-1600
21. Korula J., Balart L.A., Radvan G., et al. A prospective, randomized and controlled trial of chronic esophageal variceal sclerotherapy. Hepatology 5 (1985) 584-589
22. Williams R., and Westaby D. Endoscopic sclerotherapy for esophageal varices. Dig Dis Sci 31 Suppl 9 (1986) 108S-121S
23. Schuman B.M., Beckman J.W., Tedesco F.J., et al. Complications of endoscopic injection sclerotherapy: a review. Am J Gastroenterol 82 (1987) 823-830
24. Cohen L.B., Korsten M.A., Scherl E.J., et al. Bacteremia after endoscopic injection sclerosis. Gastrointest Endosc 29 (1983) 198-200
25. Sarles H.E., Sanowski R.A., and Talbert G. Course and complications of endoscopic variceal sclerotherapy: a prospective study of 50 patients. Am J Gastroenterol 80 (1985) 595-599
26. Haynes W.C., Sanowski R.A., Foutch P.G., et al. Esophageal strictures following endoscopic variceal sclerotherapy: clinical course and response to dilation therapy. Gastrointest Endosc 32 (1986) 202-205
27. Soehendra N., and Binmoeller K.F. Is sclerotherapy out?. Endoscopy 29 (1997) 283-284
28. de Franchis R., and Primignani M. Endoscopic treatments for portal hypertension. Semin Liver Dis 19 (1999) 439-455
29. Infante-Rivard C., Esnaola S., and Villeneuve J.P. Role of endoscopic variceal sclerotherapy in the long- term management of variceal bleeding: a meta-analysis. Gastroenterology 96 (1989) 1087-1092
30. Lai K.H., Chiang T.T., Tsai Y.T., et al. Follow-up study after endoscopic injection sclerotherapy. Chin J Gastroenterol 2 (1985) 164-170
31. Kitano S., Koyanagi N., Iso Y., et al. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Hepatology 7 (1987) 810-815
32. Kitano S., and Baatar D. Endoscopic treatment for esophageal varices: will there be a place for sclerotherapy during the forthcoming era of ligation?. Gastrointest Endosc 52 (2000) 226-232
33. Bernard B., Lebrec D., Mathurin P., et al. Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. J Hepatol 26 (1997) 312-324
34. Villanueva C., Balanzo J., Novella M.T., et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med 334 (1996) 1624-1629
35. D'Amico G., Pagliaro L., and Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 19 (1999) 475-505
36. Stiegmann G.V., and Goff J.S. Endoscopic esophageal varix ligation: preliminary clinical experience. Gastrointest Endosc 34 (1988) 113-117
37. Naga M.I., Okasha H.H., and Foda A.R. Detachable endoloop vs. band ligation for bleeding esophageal varices. Gastrointest Endosc 59 (2004) 804-809
38. Young M.F., Sanowski R.A., and Rasche R. Comparison and characterization of ulceration induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy. Gastrointest Endosc 39 (1993) 119-122
39. Bolognesi M., Balducci G., Garcia- Tsao, et al. Complications in the medical treatment of portal hypertension. Proceedings of the third Baveno international consensus workshop on definitions, methodology and therapeutic strategies. In: de Franchis R. (Ed). Portal hypertension III (2001), Blackwell Science, Oxford (UK) 180-201
40. Stiegmann G.V., Goff J.S., Michaletz-Onody P.A., et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 326 (1992) 1527-1532
41. Laine L., El-Newihi H.M., Migikovsky B., et al. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med 119 (1993) 1-7
42. Gimson A.E.S., Ramage J.K., Panos M.Z., et al. Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding esophageal varices. Lancet 342 (1993) 391-394
43. Lo G.H., Lai K.H., Cheng J.S., et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology 22 (1995) 466-471
44. Laine L., and Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. Ann Intern Med 121 (1995) 280-287
45. Lo G.H., Lai K.H., Shen M.T., et al. A comparison of the incidence of transient bacteremia and infectious sequelae after sclerotherapy and rubber band ligation of bleeding esophageal varices. Gastrointest Endosc 40 (1994) 675-679
46. Laine L. Ligation: endoscopic treatment of choice for patients with bleeding esophageal varices?. Hepatology 22 (1995) 663-665
47. Hou M.C., Lin H.C., Kuo B.I.T., et al. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: A prospective randomized trial. Hepatology 21 (1995) 1517-1522
48. Sarin S.K., Govil A., and Jain A.K. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence. J Hepatol 26 (1997) 826-832
49. Hou M.C., Lin H.C., Lee F.Y., et al. Recurrence of esophageal varices following endoscopic treatment and its impact on rebleeding: comparison of sclerotherapy and ligation. J Hepatol 32 (2000) 202-208
50. Garcia-Tsao G., Sanyal A.J., Grace N.D., et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 46 (2007) 922-938
51. Yoshida H., Mamada Y., Taniai N., et al. A randomized controlled trial of bimonthly versus biweekly endoscopic variceal ligation of esophageal varices. Am J Gastroenterol 100 (2005) 2005-2009
52. Harewood G.C., Baron T.H., and Song L.M. Factors predicting success of endoscopic variceal ligation for secondary prophylaxis of esophageal variceal bleeding. J Gastroenterol Hepatol 21 (2006) 237-241
53. Ramirez F.C., Colon V.J., Landan D., et al. The effects of the number of rubber bands placed at each endoscopic session upon variceal outcomes: a prospective, randomized study. Am J Gastroenterol 102 (2007) 1372-1376
54. Viazis N., Armonis A., Vlachogiannakos J., et al. Effects of endoscopic variceal treatment on esophageal function: a prospective, randomized study. Eur J Gastroenterol Hepatol 14 (2002) 263-269
55. Chen S.M., Lo G.H., Lai K.H., et al. Influence of endoscopic variceal ligation on esophageal motility. J Gastroenterol Hepatol 14 (1999) 231-235
56. Sauerbruch T., and Schepke M. Sclerotherapy is out-nearly. Endoscopy 29 (1997) 281-282
57. Villanueva C., Minyana J., Ortiz J., et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal rebleeding. N Engl J Med 345 (2001) 647-655
58. Lo G.H., Chen W.C., Chen M.H., et al. A prospective, randomized trial of endoscopic variceal ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology 123 (2002) 728-734
59. Patch D., Sabin C.A., Goulis J., et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 123 (2002) 1013-1019
60. Romero G., Kravetz D., Argonz J., et al. Nadolol plus isosorbide mononitrate compared with banding plus low volume sclerotherapy for prevention of variceal rebleeding in patients with cirrhosis. Hepatology 40 Suppl 1 (2004) 204A
61. Sarin S.K., Wadhawan M., Gupta R., et al. Evaluation of endoscopic variceal ligation (EVL) versus propranolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients. Dig Dis Sci 50 (2005) 1538-1547
62. Garcia-Pagan J.C., and Bosch J. Endoscopic band ligation in the treatment of portal hypertension. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 526-535
63. Lo G.H., Chen W.C., Lin C.K., et al. Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding. Hepatology 48 (2008) 580-587
64. Hayashi T., Yonezawa M., and Kuwabara T. The study on stanch clip for the treatment by endoscopy. Gastroenterol Endosc 17 (1975) 92-101
65. Hachisu T. Evaluation of endoscopic hemostasis using an improved clipping apparatus. Surg Endosc 2 (1988) 207-230
66. Yol S., Belviranli M., and Kartal T.A. Endoscopic clipping vs. band ligation in the management of bleeding esophageal varices. Surg Endosc 17 (2003) 38-42
67. Lo G.H., Lai K.H., Cheng J.S., et al. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 33 (2001) 1060-1064
68. Feretis C., Dimopoulos C., Benakis P., et al. Endoscopic hemostasis of esophageal and gastric variceal bleeding with histoacryl. Endoscopy 22 (1990) 282-284
69. Sung J.J.Y., Yeo W., Suen R., et al. Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulfate. Gastrointest Endosc 47 (1998) 235-239
70. Marvin R., and Christopher C.T. Tissue adhesives: a review. Tech Gastrointest Endosc 8 (2006) 33-37
71. Evrard S., Dumonceau J.M., Delhaye M., et al. Endoscopic histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial. Endoscopy 9 (2003) 729-735
72. Lo G.H., Lai K.H., Cheng J.S., et al. Prevalence of paraesophageal varices and gastric varices in patients achieving variceal obliteration by banding ligation and by injection sclerotherapy. Gastrointest Endosc 49 (1999) 428-436
73. Singh P., Pooran N., Indaram A., et al. Combined ligation and sclerotherapy versus ligation alone for secondary prophylaxis of esophageal variceal bleeding: a meta-analysis. Am J Gastroenterol 97 (2002) 623-629
74. Hou M.C., Chen W.C., Lin H.C., et al. A new "sandwich" method of combined endoscopic variceal ligation and sclerotherapy versus ligation alone in the treatment of esophageal variceal bleeding: a randomized trial. Gastrointest Endosc 53 (2001) 572-578
75. Umehara M., Onda M., Tajiri T., et al. Sclerotherapy plus ligation versus ligation for the treatment of esophageal varices: a prospective randomized study. Gastrointest Endosc 50 (1999) 7-12
76. Lo G.H., Lai K.H., Cheng J.S., et al. The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: a prospective, randomized trial. Hepatology 28 (1998) 391-395
77. Cheng Y.S., Pan S., Lien G.S., et al. Adjuvant sclerotherapy after ligation for the treatment of esophageal varices: a prospective, randomized long-term study. Gastrointest Endosc 53 (2001) 566-571
78. Garg P.K., Joshi Y.K., and Tandon R.K. Comparison of endoscopic variceal sclerotherapy with sequential endoscopic band ligation plus low-dose sclerotherapy for secondary prophylaxis of variceal hemorrhage: a prospective randomized study. Gastrointest Endosc 50 (1999) 369-373
79. Hashizume M., Ohta M., Kawanaka H., et al. Recurrence rate of esophageal varices with endoscopic banding ligation followed by injection sclerotherapy. [letter]. Lancet 344 (1994) 1643
80. Monici L.T., Meirelles-Santos J.O., Soares E.C., et al. Microwave coagulation versus sclerotherapy after band ligation to prevent recurrence of high risk of esophageal varices in Child-Pugh's A and B patients. J Gastroenterol 45 (2010) 204-210
81. Cipolletta L., Bianco M.A., Rotondano G., et al. Endoscopic blockade to prevent resurfacing of esophageal varices. Gastroenterology 124 (2003) 1545-1555
82. Marrero J.A., and Scheiman J.M. Prevention of recurrent variceal bleeding: as easy as A.P.C. Gastrointest Endosc 56 (2002) 600-603
83. Chen W.C., Lo G.H., Tsai W.L., et al. Emergency endoscopic variceal ligation versus somatostatin for acute esophageal variceal bleeding. J Chin Med Assoc 69 (2006) 60-67
84. Hou M.C., Lin H.C., Chen C.H., et al. Changes in portal hypertensive gastropathy after endoscopic variceal sclerotherapy or ligation: an endoscopic observation. Gastrointest Endosc 42 (1995) 139-144
85. Lo G.H., Lai K.H., Cheng J.S., et al. The effects of endoscopic variceal ligation and propranolol on portal hypertensive gastropathy: a prospective, controlled trial. Gastrointest Endosc 53 (2001) 579-584
86. Sarin S.K., Lahoti D., Saxena S.P., et al. Prevalence, classification and natural history of gastric varices: a longterm follow-up study in 568 portal hypertension patients. Hepatology 16 (1992) 1343-1349
87. Korula J., and Ralls P. The effect of chronic endoscopic sclerotherapy on portal pressure in cirrhotics. Gastroenterology 101 (1991) 800-805
88. Lo G.H., Liang H.L., Lai K.H., et al. The impact of endoscopic variceal ligation on the pressure of the portal venous system. J Hepatol 24 (1996) 74-80
89. Lo G.H., Lai K.H., Lee S.D., et al. Does propranolol maintain post-sclerotherapy variceal obliteration? A prospective randomized study. J Gastroenterol Hepatol 8 (1993) 358-362
90. Ink O., Martin T., Poynard T., et al. Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial. Hepatology 16 (1992) 912-919
91. de Franchis R., and Primignani M. Endoscopic treatments for portal hypertension. Sem Liver Dis 19 (1999) 439-455
92. Lo G.H., Lai K.H., Cheng J.S., et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology 32 (2000) 461-465
93. De la Pena J., Brullet E., Sanchez-Hernandez E., et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology 41 (2005) 572-578
94. Lo G.H., Chen W.C., Chen M.H., et al. A randomized, controlled trial of banding ligation plus drug therapy vs drug therapy alone in the prevention of esophageal variceal rebleeding. J Gastroenterol Hepatol 24 (2009) 982-987
95. Garcia-Pagan J.C., Villaneuva C., Albillos A., et al. Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: A multicenter randomized controlled trial. Gut 58 (2009) 1144-1150
96. Gonzalez R., Zamora J., Gomez-Camarero J., et al. Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann Intern Med 15 149 (2008) 109-122
97. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 120 (2001) 726-748
98. Boyer T.D. Pharmacologic treatment of portal hypertension: past, present, and future. Hepatology 34 (2001) 834-839
99. Henderson J.M. Role of distal splenorenal shunt for long-term management of variceal bleeding. World J Surg 18 (1994) 205-210
100. Chau T.N., Patch D., Chan Y.W., et al. "Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 114 (1998) 981-987
101. Le Moine O., Deviere J., Ghysels M., et al. Transjugular intrahepatic portosystemic shunt as a rescue treatment after sclerotherapy failure in variceal bleeding. Scand J Gastroenterol Suppl 207 (1994) 23-28
102. Yang C.F., Tzeng W.S., Chang J.M., et al. Experience with transjugular intrahepatic portosystemic shunts for gastroesophageal variceal bleeding. J Chin Med Assoc 57 (1996) 204-213
103. Sauer P., Hansmann J., Richter G.M., et al. Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Endoscopy 34 (2002) 690-697
104. Sanyal A.J., Freedman A.M., Luketic V.A., et al. Transjugular intrahepatic portosystemic stent shunt compared with endoscopic therapy for the prevention of recurrent variceal hemorrhage: a randomized, controlled trial. Ann Intern Med 126 (1997) 849-857
105. Papatheodoridis G., Goulis J., Leandro G., et al. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology 30 (1999) 612-622
106. Boyer T.D., and Haskal Z.J. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 41 (2005) 386-400
107. Krige J.E.J., Shaw J.M., and Bornman P.C. The evolving role of endoscopic treatment for bleeding esophageal varices. World J Surg 29 (2005) 966-973